Clinical Trial Detail

NCT ID NCT02420613
Title Study of Suberoylanilide Hydroxamic Acid (SAHA) With Temsirolimus in Children With Diffuse Intrinsic Pontine Glioma (DIPG)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

brain stem glioma

Therapies

Vorinostat

Temsirolimus

Age Groups: child

No variant requirements are available.